Dallas Hughes

Novobiotic Pharmaceuticals, Llc

$18,700,713

Attributed

$18,700,713

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $3.2M · FY2014–25

$5M$3.8M$2.5M$1.3M$0

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$18,700,713 · 6

By mechanism

R44$11,948,608 · 4

R01$6,154,703 · 1

R43$597,402 · 1

Top collaborators

No co-investigators on record.

Most similar at Novobiotic Pharmaceuticals, Llc

Same institution · by research overlap

Amy Lynn Spoering$8,494,670
Losee Lucy Ling$17,993,656

Others in their field

Top investigators on “Pharmaceutical Preparations”

Sonia M Thomas · Research Triangle Institute$701,865,642
Tracy L Nolen · Research Triangle Institute$474,487,152
David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947

Research focus

Pharmaceutical PreparationsResistancePathogenInfectionAntibioticsPropertyProductionIn VitroMycobacterium TuberculosisDoseMethicillin Resistant Staphylococcus AureusStructureStaphylococcus AureusFermentationMicrobialAcuteLipid IiiDrug ResistanceLipidsGram-Positive BacteriaMouse ModelStreptococcus PneumoniaeBacillus AnthracisTeichoic Acids